Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Toll-like Receptors in Female Reproductive Physiology and Pathology

ORIGINAL ARTICLE: Modulation of Expression of Toll‐like Receptors in the Human Endometrium

Toll-like Receptors and Spontaneous Abortion

Toll-Like Receptors in Human Papillomavirus Infection

PPRs and Gene Polymorphisms and Chlamydia Trachomatis-associated Tubal Factor Infertility

Decreased Toll-like Receptor-2 Messenger Ribonucleic Acid and Increased Toll-like Receptor-4 in the Tubal Epithelium Next to the Infiltrated Trophoblasts During Tubal Pregnancy

Expression and Significance of TLR3 in Eutopic and Ectopic Endometrium from Women with Endometriosis

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders

Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy complications

Expression and function of toll-like receptors at the maternal-fetal interface

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

TLR signaling pathway and the effects of main immune cells and epigenetics factors on the diagnosis and treatment of infertility and sterility

Potential mechanisms and therapeutic strategies for LPS-associated female fertility decline

The Gerogress in the Study of the Immune Regnlatory Role of Estrogen and Progesterone

The Interaction Between Microorganisms, Metabolites, and Immune System in the Female Genital Tract Microenvironment

Deciphering the role of female reproductive tract microbiome in reproductive health: a review

Toll-like receptors in inflammation, infection and cancer

Brucella infection and Toll-like receptors

Roles of immune microenvironment in the female reproductive maintenance and regulation: novel insights into the crosstalk of immune cells

[Progress on the Role of Toll-like Receptors in Candida Albicans Infections].

Toll-like receptors in breast cancer immunity and immunotherapy